New stock news | Puxiang Health submits application to Hong Kong Stock Exchange, ranking second among medical and care service providers in the North China region.

According to the disclosure by the Hong Kong Stock Exchange on June 30, Pu Xiang Health Holdings Limited (referred to as Pu Xiang Health) has submitted an application for listing on the Hong Kong Stock Exchange Main Board, with Shenwan Hongyuan Group (Hong Kong) and Agricultural Bank International as joint sponsors. The prospectus shows that Pu Xiang Health is a provider of integrated medical and nursing services with professional medical capabilities as its core. Unlike traditional elderly care asset management, the company is dedicated to providing integrated services including clinical diagnosis and treatment, rehabilitation care, hospice care, and other extended services to elderly people in the community. According to the report from Zacks Consulting, based on the system's revenue in 2024, the company ranks second among medical and nursing integrated service providers in North China. Interestingly, the same data shows that the company's revenue growth rate ranks first among the top five medical and nursing integrated service providers in the region from 2022 to 2024. In 2024, the company's proportion of elderly patients ranked first among the top five service providers in the market. Pu Xiang Health's medical and nursing assets have significant location advantages and first-mover advantages. Since the operation of its first medical institution in 2005, the company has accumulated over 20 years of operational management experience and insights into the needs of the middle-aged and elderly population. Currently, the company has strategically established a network of 13 medical institutions in population-dense and high aging regions such as Beijing. Given the inherent geographical attributes of the medical and nursing integrated industry, the company is able to gain patient trust by building stable doctor-patient relationships in the community. Furthermore, local regulations on the setting up of new medical institutions are expected to further consolidate the company's leading position and competitive advantage. For example, in Beijing, there are high regulatory barriers for setting up new medical institutions in the core urban areas. This allows the company to expand its patient sources by leveraging existing medical institutions and extending its service radius to adjacent communities. Due to the existence of a supply gap in the medical and nursing integrated services at the intersection of medical services and elderly care services, and with the intensification of China's aging population and the gradual advancement of the tiered diagnosis and treatment system, the potential of the medical and nursing service market (especially in community settings) will gradually increase. According to data from Zacks Consulting, the market size of China's medical and nursing integrated services is expected to increase from 263.8 billion yuan in 2024 to 695.1 billion yuan in 2034, with a compound annual growth rate of 10.2%. Additionally, according to the same source, the market size of medical and nursing integrated services in North China is expected to increase from 27.1 billion yuan in 2024 to 80 billion yuan in 2034, with a compound annual growth rate of 11.5%. In terms of performance, in the fiscal years of 2022, 2023, and 2024, Pu Xiang Health achieved revenues of approximately 255 million yuan, 422 million yuan, and 500 million yuan respectively; and profits within the year were 38.84 million yuan, 39.22 million yuan, and 43.88 million yuan respectively.